One study demonstrated that oral administration of Bifidobacterium and the anti-programmed death protein ligand 1 (anti-PD-L1) therapy abolished tumor growth, fostering dendritic cell function and CD8+ T cell priming in a melanoma pre-clinical model [51]. The gene discussed is CD8A; the disease is neoplasm.